Behind the Breakthroughs: Rare Disease Q&A with Lauren Shannon
In this Q&A, Lauren Shannon discusses her experience and the role that Medpace plays in advancing innovative rare disease therapies.
Inside the Lab: Spotlight on Molecular Innovation – Q&A with El Mustapha Bahassi, PhD
After spending 17 years at the University of Cincinnati as a researcher and faculty member, I became interested in applying...
Advancing Gene Therapy Innovation in Ophthalmology Trials
Ophthalmic gene therapy clinical trials aim to correct or replace genes in the eye to slow, halt, or reverse inherited...
Expert Perspectives on the Transforming Diabetes Clinical Trial Landscape
As innovation accelerates across diabetes and endocrinology – particularly in areas like type 1 and type 2 diabetes, cell and...
Inside the Lab: Building Histology Capabilities for Modern Clinical Trials – Q&A with Rob McGee, MD, PhD
When I joined, Medpace was expanding its histology and anatomic pathology services in response to growing Sponsor demand. What attracted...
Raising the Standard in Pediatric Migraine Clinical Trials
Featuring: Dr. Sonia Quintas, MD, MSc, Theresa Veira, MSN, MBA, and Pora Kuperman, MPH, PhD Migraine is a leading cause...
Key Highlights from Digestive Disease Week 2026
Digestive Disease Week® 2026 reinforced its position as one of the leading global forums in gastroenterology, bringing together clinicians, researchers,...
Q&A With New Medical Expert: Dr. Jack Bleesing, MD, PhD
Medpace is proud to welcome Dr. Jack Bleesing, an accomplished immunologist and board-certified physician-scientist, with 20+ years of experience to...
ASN Kidney Week: Transformative Nephrology Insights
In this blog, Dr. Ajay Srivastava, Vice President, Medical Department, reflects on these key takeaways from 2025 ASN Kidney Week...
What’s Next for ID&V? Clinical Development Trends from ESCMID Global 2026
Explore several of the key themes emerging from ESCMID Global 2026.